Quality Of Medicines Advanced By Agreement Between USP, Mexican Standards Body
August 26, 2009
Demonstrating a significant placing in charge to advancing the quality of medicines for patients on behalf of both countries, the U.S. Pharmacopeial (USP) Convention and the Permanent Commission of the Pharmacopeia of the United Mexican States (FEUM) today agreed to collaborate on the development of standards for medicines. These standards are a key component of public health, helping to make secure the identity, quality, purity, strength and consistency of medicines that patients rely on every twenty-four hours.
The Memorandum of Understanding (MOU), signed in Mexico City by Roger L. Williams, M.D., USP chief executive officer, and Pedro D. CastaƱeda Lopez, executive member of FEUM, specifies a number of areas of collaboration, including revising, updating and integrating monographs for medicines contained in the pair pharmacopeias; exchanging scientific and technical information through meetings, courses and conferences; and establishing joint reference materials, which are physical samples that make sure compliant temper. to written pharmacopeial standards. A joint work group will have existence formed to bring to maturity priorities within the next month.
“International cooperation is critical to assuring the quality of medicines, specifically in the global manufacturing environment in which they are things being so produced,” said Dr. Williams. “The importance of such an smartness should not exist understated, as patients deserve attack to mood medicines that are pure, are of the appropriate and expected strength, and are harmonious from one dose to the next - regardless of whither they live or at that place the medicines and their ingredients they select were manufactured. We look forward to expanding the scope of our work through FEUM through this Memorandum of Understanding.”
“FEUM is very pleased to engage in this important partnership with USP,” said Mr. CastaƱeda Lopez. “This agreement is one more milestone in our kinship, which affects patients in Mexico, the United States and worldwide. We look help on to our yet to be drudge on philosophical and technical matters that contribute to quality medicines for all.”
The agreement expands on activities in a previous MOU signed between USP and FEUM in October 1999.
Source:
Francine Pierson
US Pharmacopeia

